
Join to view full profile
Rainbow Blvd# 3599Kansas City, KS 66160
Phone+1 913-588-6970
Fax+1 913-588-0673
Dr. Jawdat is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- http://www.kumc.edu/school-of-medicine/neurology/faculty/omar-jawdat-md.html
Education & Training
University of Kansas School of MedicineFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014
University of Kansas School of MedicineChief Residency, Neurology, 2012 - 2013
University of Kansas School of MedicineResidency, Neurology, 2009 - 2013
University of Baghdad College of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2025 - 2028
KS State Medical License 2012 - 2027
MO State Medical License 2021 - 2027
OK State Medical License 2026 - 2027
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015-2017
Clinical Trials
- Trial of Oxaloacetate in ALS Start of enrollment: 2020 Mar 17
Publications & Presentations
PubMed
- Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.Eric Sorenson, Daragh Heitzman, Ikjae Lee, Grace Jang, Lauren Elman
Muscle & Nerve. 2026-06-01 - 1 citationsPrimary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment.Ikjae Lee, Grace Jang, Ying Kuen Ken Cheung, Alexander V Sherman, Wendy S Johnston
Annals of Neurology. 2026-02-01 - 8 citationsVerdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial., Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-04-01
Journal Articles
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)Richard J Barohn, Mamatha Pasnoor, Omar Jawdat, Mazen M Dimachkie, JAMA Neurology
- Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.van den Berg LH1, Sorenson E2, Gronseth G2, Macklin EA2, Andrews J2, Baloh RH2, Benatar M2, Berry JD2, Chio A2, Corcia P2, Genge A2, Gubitz AK2, Lomen-Hoerth C2, McDer..., Neurology, 4/2019
Authored Content
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
Press Mentions
KC Man Diagnosed with ALS Will Be Part of Highly Competitive Medical TrialApril 26th, 2021
External Links
- University Biohttp://www.kumc.edu/school-of-medicine/neurology/faculty/omar-jawdat-md.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









